Innovation Directory – Wales

Morvus Technology Limited is a privately owned pharmaceutical company who specialise in improving existing drugs which are off patent or have previously been abandoned. The company has three product lines, two of which have been licensed to other companies, with the other being developed by Gordian Pharma, a vehicle established by Morvus to develop MTL-004, a cytotoxic small molecule drug with the potential to help control cancer.

The MS Society funds and promotes research to develop new treatments and services for people with MS and to understand the causes of the condition. Support is provided to people affected by MS, with efforts to raise awareness, improve understanding, and enhance care and support for all people living with MS. The organisation operates across England, Scotland, Northern Ireland, and Wales.

My Mask Fit is a Swansea based medical device company which are developing custom-fit P3 standard transparent facemasks made by scanning a customer's face with a mobile application.

Nanopharm is a contract research organisation who provide preformulation studies, formulation solutions and analytical support during all phases of drug development of orally inhaled and nasal drug products. The company is based in Newport.

The National Cardiovascular Research Network (NCRN) supports academics, clinicians and other stakeholders from across Wales to build further critical mass in research into arrhythmia, vascular pathology and cardiovascular healthcare outcomes. The NCRN is funded by Health and Care Research Wales

The Wales National Centre for Mental Health that houses researchers from Cardiff, Swansea and Bangor Universities to research the triggers and causes of mental health problems.

The NCPHWR is a Health and Care Research Wales funded centre that houses researchers, statisticians and data analysts from Welsh universities and Public Health Wales to understand, evaluate and inform population health Improvements.

The National Institute of Health and Care Research (NIHR) is the UK Government's largest funder of clinical, public health, social care and translational research

Neem Biotech is a drug discovery company, focused on discovering small molecules to combat antibacterial resistance. Upon discovery of promising molecules, the company has created three spin-outs to further develop and commercialise these assets; Mootral, ONYA Therapeutics and Mariposa Therapeutics.

Neogen is a food safety solution provider. In 2022, the company merged with 3M Food Safety, who owned a development and manufacturing site in Bridgend. This site manufactured rapid hygiene testing and microbial screening products for use by dairy, food and beverage manufacturers.